A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

medRxiv - The Preprint Server for Health Sciences

Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity - ScienceDirect

PDF) A time-resolved proteomic and prognostic map of COVID-19

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection - eBioMedicine

Frontiers Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review

A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study - eClinicalMedicine

Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine

Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level

A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study - eClinicalMedicine

Mathematics, Free Full-Text